Biologically pure culture of Streptomyces majorciensis Labeda
US4608343A · kind A · utility
1Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 1985 |
| Grant date | Aug 26, 1986 |
| Priority date | — |
| Expiry date | May 30, 2005 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/465
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This disclosure describes four new antibacterial agents designated LL-C08078.alpha..sub.1, LL-C08078.alpha..sub.2, LL-C08078.alpha..sub.3 and LL-C08078.beta. produced in a microbiological fermentation under controlled conditions using a new strain of a new species of the genus Streptomyces called Streptomyces majorciensis Labeda, sp. nov., and mutants thereof. These new antibacterial agents are active against a variety of microorganisms and thus are useful in inhibiting the growth of such bacteria wherever they may be found. In addition, these agents are active as growth promotants in warm-blooded animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.